Panalgo and HealthEconomics.Com Host Webinar on Successful ICER Strategies
Panalgo and HealthEconomics.Com hosted a webinar detailing strategies that lead to successful evaluation by the Institute for Clinical and Economic [...]
CEVR Leaders Publish NEJM Article on Determining Value Using Cost-Effectiveness Analyses
Peter Neumann, Sc.D., Joshua Cohen, Ph.D., and Daniel Ollendorf, Ph.D. of the Center for the Evaluation of Value and Risk [...]
CEVR Director Publishes Article on Improving Data Dashboards for Drug Value Assessments
Director of the Center for the Evaluation of Value and Risk in Health (CEVR) at Tufts Medical Center Peter Neumann [...]
NPC and CEVR Researchers Find That Patient Voices Are Missing in Discussions on Drug Coverage
Researchers at the National Pharmaceutical Council (NPC) and the Center for the Evaluation of Value and Risk in Health (CEVR) [...]
CEVR Researcher and Author Dan Ollendorf Discusses QALYs, Reducing Prescription Drug Prices Using Value, and HTAs
Dr. Dan Ollendorf of the Center for the Evaluation of Value and Risk in Health (CEVR) at Tufts University Medical [...]
CEVR Researchers Publish Article on Strengths of Value-Based Healthcare and HTAs
Leading researchers at Tufts University School of Medicine’s Center for the Evaluation of Value and Risk in Health (CEVR) have [...]
CEVR Leaders Discuss Recent Book on Lowering Prescription Drug Costs
An upcoming webinar will feature drug pricing experts and authors of The Right Price: A Value-Based Prescription for Drug Costs. The [...]
CEVR Researchers Discuss External Reference Pricing in Reducing Prescription Drug Costs, Note Billions in Potential Savings
Investigators at the Center for the Evaluation and Risk in Health (CEVR) at Tufts Medical Center considered the consequences of external [...]
CEVR’s Specialty Drug Database Provides Insight Into Commercial Health Plans
The Center for the Evaluation of Value and Risk in Health (CEVR) at Tufts Medical Center has established the Specialty [...]
NPC’s Leonard Outlines Findings of Research on Coverage Decisions
National Pharmaceutical Council President and CEO Dan Leonard in a recent write up published on Pharmacy Times outlines some key [...]
